Patent intelligence · US
US 11077072
Binge behavior regulators
Binge behavior regulators
Patent details — US 11077072
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 3, 2021
- Expiration
- Jul 29, 2041
- Applicant
- CLEARMIND MEDICINE INC.
- Claims
- 13
- CPC classes
- A61K, A61K31/135, A61K31/255, A61K31/357
Quick answer
US 11077072 (Binge behavior regulators) is held by CLEARMIND MEDICINE INC.. Status: granted. Granted Aug 3, 2021. Expires Jul 29, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- CLEARMIND MEDICINE INC.
- Grant date
- Expiration
- Claims
- 13
- CPC classes
- A61K, A61K31/135, A61K31/255, A61K31/357, A61K31/36, A61K31/40
More from CLEARMIND MEDICINE INC.
Related pharmaceutical patents in our USPTO index.
Related coverage
Frequently asked questions
What is US patent 11077072?
US 11077072 (Binge behavior regulators) is held by CLEARMIND MEDICINE INC.. Status: granted. Granted Aug 3, 2021. Expires Jul 29, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11077072?
CLEARMIND MEDICINE INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 5 pharmaceutical patents for this assignee.
When does US 11077072 expire?
Our index shows an expiration date of Jul 29, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.